ZuriMED Technologies raises €14.8M Series A round
10 August 2023· Zurich, Switzerland· health, surgical_devices, biotech, materials, software_hardware, b2b
The funding will be employed to expedite ZuriMED's development and adoption of revolutionary Surgical-Fiberlock technology for minimally invasive soft tissue surgery. It will also facilitate regulatory registration of the first product targeting shoulder rotator cuff repair and address the growing surgical device market in the United States and Europe within the next three years.
Investors
LeadChindex Medical Limited
Also participating
Yellowstone Holding AGprivate investors including leading orthopaedic surgeons
About ZuriMED Technologies
Stage
Series A
Headquarters
Zurich, Switzerland
Founded
2015
Team Size
21–50
Sectors
healthsurgical_devicesbiotechmaterialssoftware_hardwareb2b